Federica Melle

1.1k total citations
18 papers, 285 citations indexed

About

Federica Melle is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Federica Melle has authored 18 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Federica Melle's work include Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (4 papers) and CAR-T cell therapy research (4 papers). Federica Melle is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (4 papers) and CAR-T cell therapy research (4 papers). Federica Melle collaborates with scholars based in Italy, United States and Switzerland. Federica Melle's co-authors include Stefano Pileri, Giovanna Motta, Valentina Tabanelli, Angelica Calleri, Stefano Fiori, Maria Rosaria Sapienza, Claudio Agostinelli, Enrico Derenzini, Alessandro Pileri and Elena Sabattini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Federica Melle

16 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federica Melle Italy	8	138	131	89	69	63	18	285
Julie C. Porcher United States	8	213 1.5×	126 1.0×	106 1.2×	100 1.4×	69 1.1×	13	399
Avery Polk United States	7	167 1.2×	139 1.1×	75 0.8×	67 1.0×	160 2.5×	14	313
Walther M. Pfeifer United States	8	167 1.2×	74 0.6×	123 1.4×	100 1.4×	40 0.6×	9	314
Miki Kiyota Japan	10	107 0.8×	93 0.7×	137 1.5×	37 0.5×	101 1.6×	23	319
Elsa Poullot France	9	134 1.0×	87 0.7×	48 0.5×	29 0.4×	73 1.2×	27	231
Ana Batlle Spain	7	151 1.1×	115 0.9×	51 0.6×	38 0.6×	28 0.4×	15	248
Kayo Tanita Japan	11	68 0.5×	219 1.7×	76 0.9×	96 1.4×	150 2.4×	34	395
Joseph Rohr United States	9	131 0.9×	82 0.6×	74 0.8×	57 0.8×	37 0.6×	20	270
Iris Amitay‐Laish Israel	10	93 0.7×	101 0.8×	50 0.6×	192 2.8×	91 1.4×	25	348
Dominique Penther France	7	73 0.5×	67 0.5×	52 0.6×	33 0.5×	33 0.5×	13	219

Countries citing papers authored by Federica Melle

Since Specialization

Citations

This map shows the geographic impact of Federica Melle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Melle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Melle more than expected).

Fields of papers citing papers by Federica Melle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Melle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Melle. The network helps show where Federica Melle may publish in the future.

Co-authorship network of co-authors of Federica Melle

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Melle. A scholar is included among the top collaborators of Federica Melle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Melle. Federica Melle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tabanelli, Valentina, Maria Rosaria Sapienza, Federica Melle, et al.. (2025). Immune Signatures Identify Patient Subsets Deriving Long‐Term Benefit From First‐Line Rituximab in Follicular Lymphoma. eJHaem. 6(1). e1103–e1103. 1 indexed citations

Talarico, Giovanna, Andrea Franceschini, Alessandro Raveane, et al.. (2024). HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients. Discover Oncology. 15(1). 764–764.

Pileri, Stefano, Valentina Tabanelli, Roberto Chiarle, et al.. (2023). Mediastinal Gray-Zone Lymphoma: Still an Open Issue. SHILAP Revista de lepidopterología. 4(3). 196–206. 1 indexed citations

Violetti, Silvia Alberti, Maria Rosaria Sapienza, Marcello Del Corvo, et al.. (2023). A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis. Cells. 12(15). 1944–1944. 2 indexed citations

Mazzara, Saveria, Laura Lavinia Travaini, Francesca Botta, et al.. (2023). Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood Advances. 7(4). 630–643. 6 indexed citations

Hartmann, Sylvia, Federica Melle, Giovanna Motta, et al.. (2023). Clonal T-cell proliferations occasionally occur in Kikuchi–Fujimoto disease. Human Pathology. 138. 103–111. 1 indexed citations

Sabattini, Elena, Alessandro Broccoli, Claudio Agostinelli, et al.. (2022). Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(5). 899–904.

Chiappella, Annalisa, Fary Diop, Claudio Agostinelli, et al.. (2021). Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial. British Journal of Haematology. 196(5). 1184–1193. 21 indexed citations

Pileri, Stefano, Valentina Tabanelli, Stefano Fiori, et al.. (2021). Peripheral T-Cell Lymphoma, Not Otherwise Specified: Clinical Manifestations, Diagnosis, and Future Treatment. Cancers. 13(18). 4535–4535. 12 indexed citations

10.

Pileri, Stefano, Claudio Tripodo, Federica Melle, et al.. (2021). Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas. Cells. 10(3). 675–675. 11 indexed citations

11.

Spriano, Filippo, Eugenio Gaudio, Luciano Cascione, et al.. (2020). Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734. Blood Advances. 4(17). 4124–4135. 53 indexed citations

12.

Sapienza, Maria Rosaria, Fabio Fuligni, Federica Melle, et al.. (2020). MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma. Hematological Oncology. 38(5). 831–833. 2 indexed citations

13.

Tabanelli, Valentina, Chiara Corsini, Stefano Fiori, et al.. (2019). Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas. Human Pathology. 90. 60–69. 30 indexed citations

14.

Laginestra, Maria Antonella, Luciano Cascione, Giovanna Motta, et al.. (2019). Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Modern Pathology. 33(2). 179–187. 47 indexed citations

15.

Sapienza, Maria Rosaria, Alessandro Pileri, Enrico Derenzini, et al.. (2019). Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects. Cancers. 11(5). 595–595. 55 indexed citations

16.

Derenzini, Enrico, Alessandra Rossi, Claudio Agostinelli, et al.. (2018). Integration of Nanostring Profiling and Functional Characterization of Oxidative and Replicative Stress Biomarkers Identifies Poor Prognosis MYC/BCL-2 Positive Diffuse Large B-Cell Lymphoma Subsets, Providing Opportunities for Precision Therapies. Blood. 132(Supplement 1). 676–676. 1 indexed citations

17.

Chiappella, Annalisa, Claudio Agostinelli, Maurizio Martelli, et al.. (2017). BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA. Hematological Oncology. 35(S2). 157–158. 2 indexed citations

18.

Gazzola, Anna, Claudia Mannu, Maura Rossi, et al.. (2014). The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies. Therapeutic Advances in Hematology. 5(2). 35–47. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact